Sale!

ELEFTHA 440

Name: ELEFTHA 440
Brand: INTAS PHARMACEUTICALS LTD
SKU: 445
Availability: InStock

TRASTUZUMAB LYOPHILIZED 440MG

2-8* C

MRP	:	~~MRP ₹19,202.10~~
Price	:	₹7,500.00
You Save	:	₹11,702.10 (60.94%)

1 vial(s)

SKU: 445 Categories: Anti-Cancer, Anti-Cancer Drugs Tag: ANTI CANCER DRUGS Brand: INTAS PHARMACEUTICALS LTD

Eleftha 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Eleftha 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

Eleftha 440mg Injection is indicated for its use in the following conditions:

Advanced and metastatic breast cancer
Metastatic gastric cancer

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Eleftha 440mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Eleftha 440mg Injection and cause undesirable side effects.

Eleftha 440mg Injection shall either be administered before or after surgery.
It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Keep Eleftha 440mg Injection out of sight and reach of children.
Store between 2˚C and 8˚C.

Serious

Heart Problems
Allergic reactions
Kidney problems
Breathing difficulties

Common

Fever
Visual disturbances
Nose bleeds or runny nose
Hair loss
Dizziness
Nail disorders
Weight loss
Loss of appetite
Bruising
Dry mouth
Liver inflammation
Muscle pain
Asthma/ lung disorders

Breast Feeding

Unsafe

Avoid breastfeeding your baby while on the treatment with Eleftha 440mg Injection atleast for at least seven months after the final dose.

Alcohol

Consult Your Doctor

Consult your doctor to know if it is safe to consume alcohol while you are on treatment with Eleftha 440mg Injection.

Liver

Consult Your Doctor

You need to tell your physician if you have any liver disorders before starting Eleftha 440mg Injection as it requires dosage adjustment for severe liver impairment.

Lungs

Consult Your Doctor

Talk to your doctor if you have any lung conditions before starting treatment with Eleftha 440mg Injection.

Driving

Unsafe

Eleftha 440mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.

Pregnancy

Unsafe

Discuss with your physician before taking this Eleftha 440mg Injection if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause to the unborn baby.